PharmChem Laboratories Inc (PCHM)

[LMLYP]

They promised more transparency in the soon to be released shareholder letter.

"Updates on this * and our expansion efforts ** will be forthcoming as they develop.


*developing other certified labs (which has been talked about in every shareholder letter)

** four additional opioids (fentanyl, buprenorphine, methadone and tramadol) and quite possibly six additional benzodiazepines. This is the first time they have publicly identified which drugs they are looking to expand the panel to.

"Sweat testing for drugs of abuse can be beneficial to medical professionals in the pain management field."

If this means that PCHM's goal is to develop medical professionals in the pain management field as new customers, would these doctors be looking for drugs of abuse on a drug test that they are not prescribing?